Terry-Ann Burrell

Insider Reports History

Entity
Individual
Location
C/O Beam Therapeutics Inc., 26 Landsdowne Street, Cambridge, MA
Signature
/s/ Jonathan Golightly, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Terry-Ann Burrell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Beam Therapeutics Inc. Chief Financial Officer Common Stock 82.6K $2.52M $30.54 Apr 26, 2024 Direct
Beam Therapeutics Inc. Chief Financial Officer Stock Option (Right to Buy) 25K $610K $24.40 Apr 26, 2024 Direct
RECURSION PHARMACEUTICALS, INC. Director Class A Common Stock 71.3K $514K $7.22 Jul 1, 2024 Direct
RECURSION PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 26.2K Jun 3, 2024 Direct

Insider Reports Filed by Terry-Ann Burrell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RXRX RECURSION PHARMACEUTICALS, INC. Jul 1, 2024 1 $0 4 Jul 3, 2024 Director
RAPP Rapport Therapeutics, Inc. Jun 6, 2024 0 $0 3 Jun 6, 2024 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 3, 2024 2 $0 4 Jun 5, 2024 Director
BEAM Beam Therapeutics Inc. Apr 26, 2024 2 $0 4 Apr 29, 2024 Chief Financial Officer
BEAM Beam Therapeutics Inc. Apr 1, 2024 1 -$175K 4 Apr 3, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Apr 1, 2024 1 $0 4 Apr 3, 2024 Director
BEAM Beam Therapeutics Inc. Mar 31, 2024 1 $0 4 Apr 2, 2024 Chief Financial Officer
BEAM Beam Therapeutics Inc. Jan 31, 2024 1 $1.34M 4 Feb 2, 2024 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Jul 12, 2023 5 -$1.41M 4 Jul 14, 2023 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
BEAM Beam Therapeutics Inc. Apr 3, 2023 2 -$138K 4 Apr 5, 2023 Chief Financial Officer
BEAM Beam Therapeutics Inc. Jan 31, 2023 1 $0 4/A Apr 19, 2023 Chief Financial Officer
BEAM Beam Therapeutics Inc. Jan 26, 2023 6 -$1.17M 4 Jan 30, 2023 Chief Financial Officer
BEAM Beam Therapeutics Inc. Jan 23, 2023 6 -$634K 4 Jan 25, 2023 Chief Financial Officer
BEAM Beam Therapeutics Inc. Jan 18, 2023 3 -$1.58M 4 Jan 20, 2023 Chief Financial Officer
RXRX RECURSION PHARMACEUTICALS, INC. Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
RXRX RECURSION PHARMACEUTICALS, INC. Oct 3, 2022 1 $0 4 Oct 5, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jul 1, 2022 1 $0 4 Jul 6, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director
BEAM Beam Therapeutics Inc. Mar 31, 2022 2 -$106K 4 Apr 4, 2022 CFO
BEAM Beam Therapeutics Inc. Jan 31, 2022 1 $0 4 Feb 2, 2022 CFO
RXRX RECURSION PHARMACEUTICALS, INC. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
RXRX RECURSION PHARMACEUTICALS, INC. Oct 1, 2021 1 $0 4 Oct 5, 2021 Director
RXRX RECURSION PHARMACEUTICALS, INC. Jul 1, 2021 1 $0 4 Jul 6, 2021 Director
BEAM Beam Therapeutics Inc. Jun 30, 2021 4 -$3.25M 4 Jul 2, 2021 CFO
BEAM Beam Therapeutics Inc. Jun 28, 2021 9 -$4.23M 4 Jun 30, 2021 CFO